MuSigmas

We empower clinical trialists to design faster, cost-effective, and regulatory-compliant trials through advanced statistical strategies.

We offer statistical planning and regulatory support for early- and late-phase clinical trials and observational studies, with expertise in Adaptive Designs including Bayesian Designs, as well as the application of machine learning for biomarker discoveries and diagnostic device development. In addition to design and analysis, we offer support in regulatory defense for clinical trial designs and protocols, and Data Monitoring Committee (DMC) related services. While we cover all therapeutic areas, we have extensive experience in Oncology, CVD, CNS, rare diseases, vaccine trials and medical devices. We are also actively involved in developing cutting-edge statistical tools and software to empower statisticians, data scientists and clinicians.

Planning for a clinical trial? Mitigate trial risk and increase efficiency with robust statistical planning — partner with us.